Filtros de reducción de priones con filtros de reducción de priones.

Same author

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Cell stem cell·2026

Same author

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Nature medicine·2025

Same author

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

Cytotherapy·2024

Same author

The infected blood inquiry report-lessons for gamete donation.

Human fertility (Cambridge, England)·2024

Same author

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Frontiers in immunology·2024

Same author

Long-range inhibition synchronizes and updates prefrontal task activity.

Nature·2023

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Filtros de reducción de priones con filtros de reducción de priones.

Videos de Conceptos Relacionados

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

The infected blood inquiry report-lessons for gamete donation.

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Long-range inhibition synchronizes and updates prefrontal task activity.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Filtros de reducción de priones con filtros de reducción de priones.

Videos de Conceptos Relacionados

Artículos Relacionados

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Harnessing global HLA data for enhanced patient matching in iPSC haplobanks.

The infected blood inquiry report-lessons for gamete donation.

EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation.

Long-range inhibition synchronizes and updates prefrontal task activity.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.